Capital raising of $13.5million to accelerate growth
Filed with ASX · · 2 pages · English
Earlier from TrivarX
- ANZ: Opes Prime Disclosure
- Outstanding 86% accuracy in 889 person Ottawa Uni study
- Quarterly Activities Report
- Receipt of $3,074,224 R & D Tax Incentive Refund
- Partners with HBF and Vital Conversations on mental health
Later from TrivarX
- Medibio enters into binding agreement with Medtronic
- Excellent performance in the pilot phase of US Validation
- Partnership with leading US University on PTSD
- Early Redemption of Convertible Note
- MEB appoints US med-tech veteran as CEO & Managing Director
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX